Quality management in clinical trials

Provided by CCRI (Children's Cancer Research Institute)

ZANDR

* Quality Management (support)
The QM always works in close cooperation with all staff members to provide cellular therapeutic agents, tissues, diagnostic services and study results of the highest quality and in compliance with legal requirements, guidelines and standards. This includes – but is not restricted to – support in the following respects:
Document management (writing, approval, distribution, version control, archiving, …)
Process management (recording of process flow diagrams, assignment of responsibilities, monitoring of process indicators, process enhancement, …)
Training and further education (conduct, management and refreshment of training)
Risk assessment and performance of risk analyses
Fault and deviation management (classification, allocation, processing and closing of errors, performance of root cause analyses and implementation of improvements)
Complaint handling
Supplier qualification (obtaining certificates or quality questionnaires, approval or blocking of suppliers, …)
Approval of maintenance, calibration and qualification reports for critical equipment
Method and process validation (defining and writing validation plans, calculating and representing results, writing validation reports, …)
Recording and reporting of side effects (pharmacovigilance, tissue vigilance, medical device vigilance)
Implementation of new standards
Auditing and monitoring including their reporting
Annual reporting (product quality reports, vigilance reports, management reports, and others)

Visit website

Trial management support

Provided by EUROPEAN CLINICAL RESEARCH INFRASTRUCTURES NETWORK (ECRIN)

ECRIN

• trial management operations (interaction with competent authorities & ethics committees, project management, monitoring, vigilance, data management)
• clinical trial tools (outcome measures, regulatory database, site locations, risk-based monitoring)

Visit website

Training on translational medicine/ TRANSMED ACADEMY

Provided by EATRIS – EUROPEAN INFRASTRUCTURE FOR TRANSLATIONAL MEDICINE

EATRIS

EATRIS offers a wide range of training, including:
– How to assess the translational potential of your project
– How to develop a collaboration with industry
– An introduction to translational medicine (this is particularly relevant for PhD students and postdocs).
– EATRIS also offers open access to an e-learning environment dedicated to translational research

Visit website

Joint Clinical Assessment (JCA) and Scientific Consultations (JSC)

Provided by European Network for Health Technology Assessment (EUNetHTA)

EUNETHTA

EUnetHTA develops several services that help inform the decision-making process around the introduction of pharmaceuticals and other technologies at the national, regional and European levels. These include Joint assessments, early diologues and Post Launch Evidence Generation (PLEG)
* Assessment submission: Health technology companies are encouraged to contact us via the following two channels if interested in a EUnetHTA assessment of their product. These are distinguished by EUnetHTA as Pharmaceuticals and Other Technologies (i.e. non-pharmaceuticals).
*Early dialogue: parallel scientific advice with the European Medicines Agency. This aims to allow medicine developers to obtain feedback from regulators and health technology assessment (HTA) bodies on their evidence-generation plans to support decision-making on marketing authorisation and reimbursement of new medicines at the same time.
* Horizon Scanning: topic identificatin, selection and Prioritisation for HTA cooperation

Visit website

Core Outcome Measures in Effectiveness Trials

Provided by CORE OUTCOME MEASURES IN EFFECTIVENESS TRIALS (COMET)

Comet

COMET stands for the ‘Core Outcome Measures in Effectiveness Trials’ Initiative. It has developed a database of all studies relevant to the development of core outcome sets for use in clinical trials. The COMET initiative was set up to help in two main ways:
*to provide the COMET database as a central point where researchers, practitioners and patients can find core outcome sets that have already been developed or are still under development.
* Provide materials to support the teams who are working on core outcome sets

Visit website

Training on medicines’ research & development and patient engagement

Provided by European Patients' Academy (EUPATI) toolbox

EUPATI

EUPATI provides training for patients and patient representatives on the end to end process of medicines research and development. Trained patient experts are the core resource for patient involvement in medicines R&D, regulatory deliberations, and other patient engagement initiatives. EUPATI is committed to changing the face of patient engagement through patient education.

Visit website

Transnational access Calls focussed on pathogenic agents

Provided by EUROPEAN RESEARCH INFRASTRUCTURE ON HIGHLY PATHOGENIC AGENTS (ERINHA)

Erinha

To facilitate Transnational access (TNA) to ERINHA’s member facilities, ERINHA periodically opens a call for applications. Free of charge TNA includes administrative & logistical support, remote use of ERINHA high containment facilities, and technical & scientific support.
Transnational Access is either:
– In person/on-site, and provided to selected Users that visit the facilities, on the necessary conditions that the users have appropriate background and successfully complete the required training
– Remote, through the provision of remote scientific services to selected Users
Note: Remote access will systematically apply for in vivo experiments

Visit website

Training eSupport System (TeSS)

Provided by ELIXIR

The Training eSupport System, TeSS, is a platform that was developed to provide a one-stop shop for trainers and trainees to discover online information and content, including training materials, events and interactive tutorials. For training providers, TeSS provides opportunities to promote training events and news, and to contribute to a growing catalogue of material

Visit website

Guide on patient partnerships in rare diseases research projects

Provided by European Joint Programme on Rare Diseases (EJP RD)

EJPRD

The EJP RD has developed a short guide on patient partnerships in rare diseases research projects. It aims to encourage fruitful, sustainable and enduring partnerships between scientists and patient organisations, co-leading the way for systematic patient-centered research.

Visit website